.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Novartis
Dow
Accenture
AstraZeneca
Johnson and Johnson
Covington
Federal Trade Commission
UBS
Harvard Business School

Generated: December 13, 2017

DrugPatentWatch Database Preview

DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

When do Delflex W/ Dextrose 1.5% Low Magnesium In Plastic Container patents expire, and what generic alternatives are available?

Delflex W/ Dextrose 1.5% Low Magnesium In Plastic Container is a drug marketed by Fresenius Medcl and is included in one NDA.

The generic ingredient in DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER is calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate. There are two hundred and seventy drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Fresenius MedclDELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINERcalcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactateSOLUTION;INTRAPERITONEAL018883-004Nov 30, 1984ATRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Dow
UBS
Mallinckrodt
Johnson and Johnson
Healthtrust
QuintilesIMS
Boehringer Ingelheim
Daiichi Sankyo
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot